Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog.
Krause, S M
Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog. [electronic resource] - Cardiovascular research Nov 1994 - 1672-8 p. digital
Publication Type: Comparative Study; Journal Article
0008-6363
10.1093/cvr/28.11.1672 doi
Animals
Coronary Vessels
Dogs
Endothelin Receptor Antagonists
Endothelins--blood
Infusions, Intravenous
Ligation
Myocardial Ischemia--blood
Myocardial Reperfusion Injury--prevention & control
Peptides, Cyclic--administration & dosage
Random Allocation
Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog. [electronic resource] - Cardiovascular research Nov 1994 - 1672-8 p. digital
Publication Type: Comparative Study; Journal Article
0008-6363
10.1093/cvr/28.11.1672 doi
Animals
Coronary Vessels
Dogs
Endothelin Receptor Antagonists
Endothelins--blood
Infusions, Intravenous
Ligation
Myocardial Ischemia--blood
Myocardial Reperfusion Injury--prevention & control
Peptides, Cyclic--administration & dosage
Random Allocation